Rapiflo™

Silodosin
BPH Preparations (Urological Preparations)

Indication:

Treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Dosage & Administration:

• The recommended dose is 8 mg orally once daily with a meal.
• In patients with moderate renal impairment [Creatinine Clearance (CCr) 30-50 mL/min] and in moderate LUTS, dose is 4 mg orally once daily with a meal.

Preparation:

Rapiflo^TM8 Capsule : Each box contains 20 capsules in blister packs.
Rapiflo^TM4 Capsule : Each box contains 30 capsules in blister packs.